Piramal Pharma Clarifies $1.7 Million Government Funding for Aurora Facility
Piramal Pharma Ltd 路 Others (Uncategorized) 路 02 Oct 2026, 12:33 am
Piramal Pharma Clarifies $1.7 Million Government Funding for Aurora Facility Piramal Pharma clarified that its Aurora facility received a $1.7M funding grant from the Government of Ontario under the Life Sciences Scale-Up Fund program to support infrastructure upgrades, modernization, and operational efficiency. The company stated that this funding is non-material under SEBI Regulation 30, with no expected material impact on financial performance or operations. Additionally, management confirmed that any recent movements in share price or trading volume are purely market-driven, with no undisclosed material information.
Original exchange filing (PDF)
More announcements from Piramal Pharma Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund 路 31 Oct 2026
- Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI LODR Regulations, 2015 路 30 Oct 2026
- Please find enclosed details of Earning call Transcript held on 28th October 2026. 路 30 Oct 2026
- Please find enclosed intimation of audio recordings of the conference call held today 28th October, 2026. 路 28 Oct 2026
- Please find enclosed Investor presentation for quarter ended 30 September, 2026 路 28 Oct 2026
- Please find enclosed Press release for quarter ended 30 September, 2026 路 28 Oct 2026
- Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 28 Oct 2026
- Please find enclosed unaudited financial results for Q2 FY 27 路 28 Oct 2026
